Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lon peptidase 1, mitochondrial (LonP1) is an ATP-dependent serine protease of the mitochondrial matrix, responsible for proteolytic removal of misfolded or damaged proteins, ensuring maintenance of mitochondrial protein homeostasis[1][2][3][4]. It also exhibits chaperone-like activity and binds mitochondrial DNA, playing direct roles in mitochondrial DNA replication and gene expression regulation, including the degradation of TFAM, to maintain mtDNA/TFAM ratios and support mitochondrial biogenesis[1][3]. Disruption or dysregulation of LonP1 activity is linked to multiple human diseases—cancer, neurodegeneration, cardiovascular, and heritable mitochondrial disorders—and LonP1 is under investigation as a therapeutic target[2][3][4]. High expression or mutation can serve as a disease biomarker; however, LonP1 is essential and loss-of-function is not tolerated in mammals[3].\nStructurally, human LONP1 contains substrate recognition, ATPase, and proteolytic domains, and operates as a homohexameric complex, with advanced conformational regulation depending on both substrate and nucleotide binding[1][4].
Protease inhibition (prevents degradation of specific mitochondrial proteins, alters protein quality control)\nModulation of mitochondrial function by stabilizing or destabilizing mitochondrial proteostasis and metabolism[2][4]\nMetabolic reprogramming (by influencing the fate of pyruvate and mitochondrial energy balance)[2]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lon peptidase 1, mitochondrial (LonP1).